Ralph Buttyan

9.4k total citations · 1 hit paper
113 papers, 7.6k citations indexed

About

Ralph Buttyan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ralph Buttyan has authored 113 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 37 papers in Pulmonary and Respiratory Medicine and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ralph Buttyan's work include Prostate Cancer Treatment and Research (34 papers), Hormonal and reproductive studies (16 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Ralph Buttyan is often cited by papers focused on Prostate Cancer Treatment and Research (34 papers), Hormonal and reproductive studies (16 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Ralph Buttyan collaborates with scholars based in United States, France and Canada. Ralph Buttyan's co-authors include Carl A. Olsson, Aaron E. Katz, Anthony J. Raffo, Marc Colombel, Min‐Wei Chen, Harris Perlman, Ihor S. Sawczuk, Mitchell C. Benson, Kathleen O’Toole and Dominique Chopin and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Ralph Buttyan

113 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

1993 519 citations Marc Colombel, Kathleen O’Toole et al. profile →

Peers

Countries citing papers authored by Ralph Buttyan

Since Specialization

Citations

This map shows the geographic impact of Ralph Buttyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Buttyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Buttyan more than expected).

Fields of papers citing papers by Ralph Buttyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Buttyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Buttyan. The network helps show where Ralph Buttyan may publish in the future.

Co-authorship network of co-authors of Ralph Buttyan

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Buttyan. A scholar is included among the top collaborators of Ralph Buttyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Buttyan. Ralph Buttyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management 2019 ·European Urology ·Varune Rohan Ramnarine, Maxim Kobelev, Ewan A. Gibb, Mannan Nouri, Dong Lin, Yuzhuo Wang, Ralph Buttyan, Elai Davicioni, Amina Zoubeidi, Colin C. Collins	82
2	A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome 2018 ·Oncogene ·Nataly Stylianou, Melanie Lehman, Chenwei Wang, Atefeh Taherian Fard, Anja Rockstroh, Ladan Fazli, Lidija Jovanovic, Micheal Ward, Martin C. Sadowski, Abhishek S. Kashyap, Ralph Buttyan, Martin Gleave, Thomas F. Westbrook, Elizabeth D. Williams, Jennifer H. Gunter, Colleen C. Nelson, Brett G. Hollier	79
3	Paracrine hedgehog increases the steroidogenic potential of prostate stromal cells in a Gli‐dependent manner 2011 ·The Prostate ·Elina Levina, Mengqian Chen, (unknown), Michael Shtutman, Ralph Buttyan	18
4	Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders 2011 ·Cell Cycle ·Anna B. Glinskii, Shuang Ma, (unknown), (unknown), Chang‐Uk Lim, Ian Guest, Stewart Sell, Ralph Buttyan, Gennadi V. Glinsky	20
5	Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy 2010 ·Cancer Research ·Guillaume Ploussard, Stéphane Terry, Pascale Maillé, Yves Allory, Nanor Sirab, Laurence Kheuang, Pascale Soyeux, Nathalie Nicolaı̈ew, (unknown), Bernard Paule, Laurent Salomon, Stéphane Culine, Ralph Buttyan, Francis Vacherot, Alexandre de la Taille	121
6	Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells 2009 ·Cell Cycle ·Mengqian Chen, Matthew Tanner, Alice C. Levine, Elina Levina, Patrice Ohouo, Ralph Buttyan	61
7	Clinical trials of natural products as chemopreventive agents for prostate cancer 2006 ·Expert Opinion on Investigational Drugs ·Debra L. Bemis, Aaron E. Katz, Ralph Buttyan	57
8	The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer 2006 ·Current Urology Reports ·Debra L. Bemis, Jillian L. Capodice, (unknown), George C. Vorys, Aaron E. Katz, Ralph Buttyan	12
9	The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer 2006 ·Current Oncology Reports ·Debra L. Bemis, Jillian L. Capodice, (unknown), George C. Vorys, Aaron E. Katz, Ralph Buttyan	9
10	Complementary and Alternative Medicine for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 2005 ·Evidence-based Complementary and Alternative Medicine ·Jillian L. Capodice, Debra L. Bemis, Ralph Buttyan, Steven A. Kaplan, Aaron E. Katz	45
11	HERBAL THERAPY PC-SPES: IN VITRO EFFECTS AND EVALUATION OF ITS EFFICACY IN 69 PATIENTS WITH PROSTATE CANCER 2000 ·The Journal of Urology ·Alexandre de la Taille, Ralph Buttyan, Omar Hayek, Emilia Bagiella, Ahmad Shabsigh, Martin Burchardt, Tatjana Burchardt, Dominique Chopin, Aaron E. Katz	53
12	Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castration 2000 ·The Prostate ·Martin Burchardt, Tatjana Burchardt, Min Wei Chen, Omar Hayek, (unknown), Ahmad Shabsigh, Alexandre de la Taille, Ralph Buttyan	35
13	Expression of Messenger Ribonucleic Acid Splice Variants for Vascular Endothelial Growth Factor in the Penis of Adult Rats and Humans1 1999 ·Biology of Reproduction ·Martin Burchardt, Tatjana Burchardt, Min‐Wei Chen, Ahmad Shabsigh, Alexandre de la Taille, Ralph Buttyan, Ridwan Shabsigh	66
14	Rapid reduction in blood flow to the rat ventral prostate gland after castration: Preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival 1998 ·The Prostate ·Ahmad Shabsigh, David T. Chang, Daniel F. Heitjan, Alex Kiss, Carl A. Olsson, Peter J. Puchner, Ralph Buttyan	143
15	Androgen induction of DNA synthesis in the rat penis 1998 ·Urology ·Ridwan Shabsigh, (unknown), Carl A. Olsson, Kathleen O’Toole, Ralph Buttyan	27
16	Peptide growth factors in normal and hypertrophied bladder 1995 ·World Journal of Urology ·(unknown), Robert M. Levin, Ralph Buttyan	22
17	Bladder Function in Experimental Outlet Obstruction: Pharmacologic Responses to Alterations in Innervation, Energetics, Calcium Mobilization, and Genetics 1995 ·Advances in experimental medicine and biology ·Robert M. Levin, Niels Haugaard, (unknown), Ralph Buttyan, Min‐Wei Chen, Frederick C. Monson, (unknown)	39
18	Enhanced Expression of p53 mRNA and Protein in the Regressing Rat Ventral Prostate Gland 1994 ·Biochemical and Biophysical Research Communications ·Xiaoquan Zhang, Marc Colombel, Anthony J. Raffo, Ralph Buttyan	23
19	Sulfated Glycoprotein‐2 Induced Endogenous Resistance to Ischemia and Reperfusion Injury in the Seminiferous Tubules 1991 ·American Journal of Reproductive Immunology ·Ilan Leibovitch, Ralph Buttyan	9
20	Gene activity during regression of androgen dependent tissues 1988 ·Ralph Buttyan, Ihor S. Sawczuk, Michael Benson, Craig A. Olsson, James Connor, Han Cheng, Paul S. Rennie, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact